Misganaw, Burook
Guffanti, Guia
Lori, Adriana
Abu-Amara, Duna
Flory, Janine D.
Hammamieh, Rasha
Gautam, Aarti
Yang, Ruoting
Daigle, Bernie J. Jr
Hood, Leroy
Wang, Kai
Lee, Inyoul
Mellon, Synthia H.
Wolkowitz, Owen M.
Mueller, Susanne
Yehuda, Rachel
Jett, Marti
Marmar, Charles R.
Ressler, Kerry J.
Doyle, Francis J. III
,
Funding for this research was provided by:
United States Department of Defense | United States Army | Army Medical Command | Medical Research and Materiel Command (W911NF-17-2-0086, W911NF-17-2-0086, W911NF-17-2-0086, W911NF-17-2-0086)
United States Department of Defense | United States Army | Army Medical Command | Telemedicine and Advanced Technology Research Center (W911NF-17-2-0086, W911NF-17-2-0086, W911NF-17-2-0086, W911NF-17-2-0086, W911NF-17-2-0086, W911NF-17-2-0086)
United States Department of Defense | United States Army | Army Medical Command | Armed Forces Institute of Regenerative Medicine (W911NF-17-2-0086)
Article History
Received: 11 April 2019
Accepted: 7 May 2019
First Online: 7 June 2019
Conflict of interest
: K.J.R. is on the scientific advisory boards for Resilience Therapeutics, the Sheppard Pratt–Lieber Research Institute, the Laureate Institute for Brain Research, the Army Study to Assess Risk and Resilience in Service members (STARRS) project, the University of California–San Diego VA Center of Excellence for Stress and Mental Health (CESAMH) and the Anxiety and Depression Association of America; provides fee-for-service consultation for Biogen and Resilience Therapeutics; and holds patents for the use of <scp>d</scp>-cycloserine and psychotherapy, targeting the pituitary adenylate cyclase-activating polypeptide (PACAP) type 1 receptor for extinction, targeting tachykinin 2 for prevention of fear and targeting angiotensin to improve extinction of fear. C.R.M. is on the scientific advisory board and have equity in Receptor Life Sciences, Inc; has served as a PTSD fellow for the George W. Bush Institute; received research and clinical program funding from the National Institute on Alcohol Abuse and Alcoholism (NIAAA), National Institute of Mental Health (NIMH), US Department of Defense (DoD), US Army Medical Research & Acquisition Activity (USAMRA), US Army Telemedicine & Advanced Technology Research Center (TATRC), Northern California Institute for Research and Education (NCIRE), Steven & Alexandra Cohen Foundation, Cohen Veterans Bioscience (CVB), Cohen Veterans Network (CVN), Robin Hood Foundation, McCormick Foundation, Home Depot Foundation, Bank of America Foundation, Brockman Foundation, and the City of New York. All other authors declare no competing interests.
: The views, opinions, and findings contained in this report are those of the authors and should not be construed as official Department of the Army position, policy, or decision, unless so designated by other official documentation. Citations of commercial organizations or trade names in this report do not constitute an official Department of the Army endorsement or approval of the products or services of these organizations.